Study on ACTengine® IMA203/IMA203CD8 Alone or with Nivolumab for Treating Recurrent or Hard-to-Treat Solid Tumors | Clinical Trial

Study on ACTengine® IMA203/IMA203CD8 Alone or with Nivolumab for Treating Recurrent or Hard-to-Treat Solid Tumors | Clinical Trial | Right2Hope